tiprankstipranks
Poseida Therapeutics founder and executive chairman Eric Ostertag to retire
The Fly

Poseida Therapeutics founder and executive chairman Eric Ostertag to retire

Earlier this evening, Poseida Therapeutics announced that Eric Ostertag, M.D., Ph.D., has resigned as Executive Chairman and will retire from the Board of Directors effective February 3, 2023. However, Dr. Ostertag will continue as a consultant to the Company to advise on technical and scientific matters. Dr. Ostertag said: "I founded Poseida eight years ago as a spinout of a genetic engineering company called Transposagen to revolutionize cell and gene therapeutics by moving away from more traditional, first-generation virus-based approaches. After leading and growing Transposagen and then Poseida as CEO for approximately 20 years, I decided to transition to the Executive Chairman role in February 2022. I have decided now is the time for me to focus more on my family and retire from this role. It has been an honor to lead the many talented employees who have built Poseida into a leading genetic engineering Company and a privilege to create therapeutics that have the potential to help numerous patients with unmet medical need. I am confident that the Poseida Board, Poseida leadership and all the extremely talented Poseida employees are well positioned to continue advancing Poseida’s cell and gene therapies with the capacity to cure." Shares are down 8.1% afterhours at $6.40.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on PSTX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles